after that horrible miss last night. Looks like it will open down 26%...
Keep in mind tho that Eisai and Pfizer have a history of working together, so while this is true I don't think they would be opposed to it.
The drug is already approved we are only going to expand the indication. So at this point it will be an efficacy study to determine if the drug works. Safety issues have already been dealt with...
Nice try tho.
Well, we actually have 600 reps. Chantix was not competing against a safer drug with a better profile that did not have a black box warning. What do you think MD's will think when a sales rep comes in from Takeda a company that just got nailed selling a drug they knew was dangerous, with anew approved weight loss drug with a black box label? I don't think it is going to be an easy sell.
They don't want the truth or the facts.. Real world results are knocking the trial results out of the water
I was very wrong about how low this could go I have stated that already several times. But I am looking long term. I am not going to say we are close to the bottom, I have thought that one to many times... It is what it is and I can't do anything about it, I will just use the fire sales to add to my positions or just sit through all of the games.
Hind sight is always 20/20 and you never know. I can't tell you how many times I bought a stock for all the right reasons, sold a large bump up looking to buy it back lower and that never happened... With Arena it is not worth the risks, buy and hold for retirement.
Why do you always need to make it nasty and personal? Are angry because you can't change everyone's opinion to yours? Traders are the only ones that care about charts. Long term investors buy the science that the vision of the company 2,3, 5 years out. We make our investment and as long as the company executes and continues to move forward we Stay the Course. Only when things fundamentally change do we reevaluate the investment. Long term investors buy shares, they don't play options or margin, they don't try to over think things.
We lock our money away at a price we feel is a discount to where the company will be in the future based on our DD and opinion. That is what makes the market you can disagree with us. Fine do so, but not everyone trades or speculates like you do. Many on here started DCAing back at 1.50-1.90 so all that has happened is they have given up profit in the short run.
The 12-15, shorts do not want to be short after this. Doctors will get to hear the facts about Belviq and get to ask questions. More data to ease their concerns from Fen Phen past and the benefits of Belviq for pre diabetics. A lot of doctors will be attending this conference.
We already know what they are going to spend they told us. This is nothing new, we have a monster pipeline with more then one billion dollar blockbuster being being moved through the pipeline.
ARNA employees are just like you and I, they go to work to make money and pay their bills. Many of the Arena employees are buying stock through their ESOPs and other bonus options... IF they were money managers or traders they would not be working for Arena they would be on Wall Street.
We have over 200 million in the bank and about 40 million a year coming in going forward, what are you talking about?
I am sure they got some longs to sell at this point. I agree we have nothing in reality happening that warrants this kind of sell off the last few weeks. We are executing and that is the key. Scripts are growing, we are gaining market share, the market for people taking weight loss drugs is growing, studies are completed and data is getting analyzed. We are moving the pipeline forward and before the end of the year we should see the Bel PHen study data and the Belviq for smoking study data. Unofficial results are very positive. Insurance coverage is growing which should get more people reordering Belviq.
These sanctioned bear raids unfortunately are part of the markets these days. We just have to learn to live with them.
Nice find. Is this study parallel to our long term mace study for 5 years required by the FDA for this new and novel compound? Seems to have a little more going on in it. Unknown if this is the study needed to get EU approval moving forward, we pulled because of the non clinical study looking into the rat tumors....
Found not duration or time line for the study.